These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2464062

  • 21. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B, Pelaprat D, Durieux C, Dor A, Reibaud M, Blanchard JC, Roques BP.
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
    [Abstract] [Full Text] [Related]

  • 22. Investigation on the metabolism of CCK8 analogues by rat brain slices.
    Durieux C, Charpentier B, Pelaprat D, Roques BP.
    Neuropeptides; 1986 Jan; 7(1):1-9. PubMed ID: 3456492
    [Abstract] [Full Text] [Related]

  • 23. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
    Sugg EE, Serra M, Shook JE, Yamamura HI, Burks TF, Korc M, Hruby VJ.
    Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563
    [Abstract] [Full Text] [Related]

  • 24. 1H NMR conformational study of sulfated and non-sulfated cholecystokinin fragment CCK27-33: influence of the sulfate group on the peptide folding.
    Durieux C, Belleney J, Lallemand JY, Roques BP, Fournie-Zaluski MC.
    Biochem Biophys Res Commun; 1983 Jul 29; 114(2):705-12. PubMed ID: 6882451
    [Abstract] [Full Text] [Related]

  • 25. Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations.
    Fournié-Zaluski MC, Belleney J, Lux B, Durieux C, Gérard D, Gacel G, Maigret B, Roques BP.
    Biochemistry; 1986 Jul 01; 25(13):3778-87. PubMed ID: 3741836
    [Abstract] [Full Text] [Related]

  • 26. [3H] Boc [Nle28, 31]CCK27-33, a new highly labelled ligand for CCK receptors: binding on brain and on pancreas.
    Pélaprat D, Zajac JM, Gacel G, Durieux C, Morgat JL, Sasaki A, Roques BP.
    Life Sci; 1985 Dec 30; 37(26):2483-90. PubMed ID: 3001463
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
    Martinez J, Winternitz F, Bodanszky M, Gardner JD, Walker MD, Mutt V.
    J Med Chem; 1982 May 30; 25(5):589-93. PubMed ID: 6177857
    [Abstract] [Full Text] [Related]

  • 28. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN, St-Pierre S, Gaudreau P.
    J Pharmacol Exp Ther; 1984 Aug 30; 230(2):438-44. PubMed ID: 6086888
    [Abstract] [Full Text] [Related]

  • 29. Effects of a new cholecystokinin antagonist (GE 410) on the smooth muscle of the guinea pig ileum.
    Rakovska A, Milenov K, Henklein P.
    Experientia; 1990 Oct 15; 46(10):1037-41. PubMed ID: 2226719
    [Abstract] [Full Text] [Related]

  • 30. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 31. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
    Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP.
    J Med Chem; 1993 Jan 08; 36(1):166-72. PubMed ID: 8421283
    [Abstract] [Full Text] [Related]

  • 32. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
    Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM.
    J Med Chem; 1992 May 29; 35(11):2007-14. PubMed ID: 1375964
    [Abstract] [Full Text] [Related]

  • 33. [Improved synthesis of the highly active cholecystokinin sequence succinyl Tyr (OSO3-)-Met-Gly-Trp-Asp-Phe-NH2].
    Henklein P, Penke B, Georgi M, Halatsch WR, Niedrich H, Ott T.
    Pharmazie; 1987 Jun 29; 42(6):413-4. PubMed ID: 3671462
    [No Abstract] [Full Text] [Related]

  • 34. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 29; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 35. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
    de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP.
    J Nucl Med; 1999 Dec 29; 40(12):2081-7. PubMed ID: 10616889
    [Abstract] [Full Text] [Related]

  • 36. Suc-Tyr(SE)-Met-Gly-Trp-Met-Asp-beta-phenethylamide(410): a competitive antagonist of cholecystokinin-induced contractions in smooth muscles in vitro.
    Rakovska A, Henklein P, Milenov K, Nieber K, Oehme P.
    Methods Find Exp Clin Pharmacol; 1987 Jul 29; 9(7):429-35. PubMed ID: 3683016
    [Abstract] [Full Text] [Related]

  • 37. Role of sulfate ester in influencing biologic activity of cholecystokinin-related peptides.
    Vinayek R, Jensen RT, Gardner JD.
    Am J Physiol; 1987 Feb 29; 252(2 Pt 1):G178-81. PubMed ID: 2435164
    [Abstract] [Full Text] [Related]

  • 38. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H, Tsunoda Y, Owyang C.
    Am J Physiol; 1997 Sep 29; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [Abstract] [Full Text] [Related]

  • 39. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
    Villanueva ML, Martinez J, Bodanszky M, Collins SM, Jensen RT, Gardner JD.
    Am J Physiol; 1982 Sep 29; 243(3):G214-7. PubMed ID: 6180646
    [Abstract] [Full Text] [Related]

  • 40. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
    Steardo L, Knight M, Tamminga CA, Chase TN.
    Neurosci Lett; 1985 Mar 15; 54(2-3):319-25. PubMed ID: 2986058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.